Antimicrobial resistance at a crossroads: the cost of inaction
- PMID: 39265589
- PMCID: PMC11476572
- DOI: 10.1016/S0140-6736(24)01705-7
Antimicrobial resistance at a crossroads: the cost of inaction
Conflict of interest statement
The findings and conclusions in this Comment are those of the authors and do not necessarily represent the official position of the US Centers for Disease Control and Prevention. We declare no competing interests.
Similar articles
-
When Action-Inaction Framing Leads to Higher Escalation of Commitment: A New Inaction-Effect Perspective on the Sunk-Cost Fallacy.Psychol Sci. 2018 Apr;29(4):537-548. doi: 10.1177/0956797617739368. Epub 2018 Feb 5. Psychol Sci. 2018. PMID: 29401001 Free PMC article.
-
Naïve Definitions of Action and Inaction: The Continuum, Spread, and Valence of Behaviors.Eur J Soc Psychol. 2012 Mar;42(2):227-234. doi: 10.1002/ejsp.860. Eur J Soc Psychol. 2012. PMID: 23487013 Free PMC article.
-
Cost saving analysis of prediabetes intervention modalities in comparison with inaction using Markov state transition model-A multiregional case study.J Diabetes. 2024 May;16(5):e13553. doi: 10.1111/1753-0407.13553. J Diabetes. 2024. PMID: 38664882 Free PMC article.
-
The risk/benefit of predicting a post-antibiotic era: is the alarm working?Ann N Y Acad Sci. 2014 Sep;1323:1-10. doi: 10.1111/nyas.12399. Epub 2014 Apr 16. Ann N Y Acad Sci. 2014. PMID: 24738913 Review.
-
Antibiotic resistance: consequences of inaction.Clin Infect Dis. 2001 Sep 15;33 Suppl 3:S124-9. doi: 10.1086/321837. Clin Infect Dis. 2001. PMID: 11524708 Review.
References
-
- Hutchings M, Truman A, Wilkinson B. Antibiotics: past, present and future. Curr Opin Microbiol 2019; 51: 72–80. - PubMed
-
- Centers for Disease Control and Prevention. 2022 Special report: COVID-19—U.S. impact on antimicrobial resistance. 2022. https://www.cdc.gov/drugresistance/pdf/covid19-impact-report-508.pdf (accessed Aug 12, 2024).
-
- Nanayakkara A, Boucher H, Fowler V Jr, Jezek A, Outterson K, Greenberg DE. Antibiotic resistance in the patient with cancer: escalating challenges and paths forward. CA Cancer J Clin 2021; 71: 488–504. - PubMed
-
- Jona O, Irwin A, Berthe F, Le Gall F, Marquez P. Drug-resistant infections: a threat to our economic future (vol 2): final report. World Bank. 2017. http://documents.worldbank.org/curated/en/323311493396993758/final-report (accessed Aug 12, 2024).
Grants and funding
LinkOut - more resources
Full Text Sources